XIX International AIDS Conference


TUSY08 Public Health-Oriented Management of Intellectual Property Rights: Overcoming Barriers to Access for Second Line ARV Drugs
  Symposia Session
Venue: Session Room 6
Time: 24.07.2012, 16:30 - 18:00
Chair: Denis Broun, Switzerland
 
 
Reducing costs of treatment regimens is one of the five pillars of the Treatment 2.0 platform launched by UNAIDS and the World Health Organization in 2010. Intellectual Property Rights (IPR) still remain a critical barrier to implementing innovative approaches to achieve more affordable prices. Even following the Doha Declaration adoption in 2001, developing countries face difficulties to making full use of Trade-Related Aspects of Intellectual Property Rights (TRIPS) flexibilities. Bilateral trade agreements are another area of concern and the patent status for newer antiretroviral medications in manufacturer countries may hamper generic competition. The objective of this symposia session is to review lessons learned since the Doha Declaration, and identify opportunities for the future to provide options for maintaining and expanding the gains that the global community has made in equitable and universal access to HIV treatment.

16:30
Introduction



16:37
TUSY0801
Webcast
ARV needs in the framework of Treatment 2.0


S. Zaidi, Thailand

16:49
TUSY0802
Webcast
Implementing TRIPS flexibilities: experiences from the ground


M. Vieira, Brazil

17:01
TUSY0803
Recent IP developments in India and their impact on access to essential medicines in the global south


K. Bhardwaj, India

17:13
TUSY0804
Webcast
Alternative models and strategies for IPR management


B. Baker, United States

17:25
TUSY0805
Webcast
Innovative initiatives to stimulate research and development within the health sector


T. Amin, United States

17:37
Questions and answers





   

    The organizers reserve the right to amend the programme.


Contact Us | Site map © 2012 International AIDS Society